Cell Therapy and Biologic Medicinal Products administrador 16/11/2022
CELL THERAPY

Cell Therapy and Biologic Medicinal Products

célulahc
secretoma

Cell-based drugs for human use.

Drugs for human use
based on substances secreted by the cells.

Cell Therapy Programs

Our experience with adult mesenchymal stem cells
Stem cells

Most basal mesenchymal stem cells die immediately after transplantation, limiting their therapeutic potential.

Oxidative stress

During the acute phase of the disease, tissue is exposed to a highly damaging environment, with persistent oxidative stress and pathological inflammation.

INNOVATIVE CELL THERAPY PLATFORM
HC016 Cells
PROPRIETARY INNOVATION
  • New allogeneic adult mesenchymal stem cell technology for oxidative stress-mediated pathologies.
  • Cells obtained from adipose tissue under a process patented by Histocell.
  • Higher survival and bioactivity than basal mesenchymal cells in oxidative and inflammatory environments: proven increase in therapeutic efficacy.

Indications:

  • Pathologies associated with a highly oxidative microenvironment are particularly suitable targets for HC016 cells.
  • Treatment of diseases with a relevant inflammatory component.
RATIONALE

Enhanced therapeutic effect of mesenchymal stem cells (HC016), increasing anti-inflammatory and antioxidant response.

  • HC016 is configured to act in pro-inflammatory environments and aims to protect damaged host tissues.
  • HC016 cells activate self-defence pathways against oxidative stress and inflammatory environments.
CELL THERAPY
ASC cell-based therapeutic programmes